Citi upgraded Travere Therapeutics to Buy from Neutral with a $10 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TVTX:
- Travere Therapeutics price target lowered to $19 from $23 at JPMorgan
- Travere Therapeutics to Present at the 6th Annual Evercore ISI HealthCONx Conference
- Travere Therapeutics initiated with a Neutral at Citi
- Travere Therapeutics Reports Third Quarter 2023 Financial Results
- TVTX Upcoming Earnings Report: What to Expect?